Insider · CIK 0001078202

FRYKMAN EDWARD W

Reports to the SEC for 2 companies · PASADENA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001078202

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-01-01	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+25K sh	—	—	148,852
2017-03-15	ACTGACACIA RESEARCH CORP · Stock Option (Right to Buy)A Award	Director	AAward	+54.3K sh	—	—	54,299
2017-01-01	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+50K sh	—	—	123,852
2016-08-01	ACTGACACIA RESEARCH CORP · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2016-03-01	ACTGACACIA RESEARCH CORP · Stock Option (Right to Buy)A Award	Director	AAward	+89.6K sh	—	—	89,552
2016-01-01	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+25K sh	—	—	73,852
2015-03-04	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+25K sh	—	—	48,852
2015-01-02	ACTGACACIA RESEARCH CORPA Award	Director	AAward	+7,177 sh	—	—	73,290
2014-02-07	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	77,500
2014-02-07	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$10.00	+$50K	27,000
2014-02-07	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,148 sh	$15.98	−$50.3K	23,852
2014-02-06	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+15K sh	—	—	22,000
2014-01-02	ACTGACACIA RESEARCH CORPA Award	Director	AAward	+8,374 sh	—	—	66,113
2013-09-21	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock OptionA Award	Director	AAward	+7,000 sh	—	—	82,500
2013-05-06	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock OptionA Award	Director	AAward	+5,000 sh	—	—	75,500
2013-03-21	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock OptionA Award	Director	AAward	+15K sh	—	—	70,500
2013-03-21	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock OptionA Award	Director	AAward	−15K sh	—	—	70,500
2012-12-11	ACTGACACIA RESEARCH CORPA Award	Director	AAward	+5,000 sh	—	—	57,739
2012-09-28	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock OptionA Award	Director	AAward	−10K sh	—	—	55,500
2012-03-01	ACTGACACIA RESEARCH CORPA Award	Director	AAward	+598 sh	—	—	52,574
2012-02-16	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock OptionA Award	Director	AAward	−15K sh	—	—	32,000
2012-01-03	ACTGACACIA RESEARCH CORPA Award	Director	AAward	+2,455 sh	—	—	51,976
2011-08-08	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock OptionA Award	Director	AAward	−40K sh	—	—	305,000
2011-02-22	ACTGACACIA RESEARCH CORPA Award	Director	AAward	+1,824 sh	—	—	49,521
2011-01-03	ACTGACACIA RESEARCH CORPA Award	Director	AAward	+1,940 sh	—	—	47,697
2010-12-08	ACTGACACIA RESEARCH CORP · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2010-12-08	ACTGACACIA RESEARCH CORPM Exercise/Conversion	Director	MExercise/Conversion	+12.4K sh	$6.94	+$86.1K	58,157
2010-12-08	ACTGACACIA RESEARCH CORPM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$13.38	+$201K	73,157
2010-12-08	ACTGACACIA RESEARCH CORPS Sale	Director	SSale	−27.4K sh	$29.27	−$802K	45,757
2010-12-08	ACTGACACIA RESEARCH CORP · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−12.4K sh	—	—	0
2010-12-07	ACTGACACIA RESEARCH CORPM Exercise/Conversion	Director	MExercise/Conversion	+4,200 sh	$2.19	+$9,198	63,157
2010-12-07	ACTGACACIA RESEARCH CORP · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,200 sh	—	—	0
2010-12-07	ACTGACACIA RESEARCH CORP · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2010-12-07	ACTGACACIA RESEARCH CORP · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2010-12-07	ACTGACACIA RESEARCH CORP · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,600 sh	—	—	12,400
2010-12-07	ACTGACACIA RESEARCH CORP · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−13.2K sh	—	—	0
2010-12-07	ACTGACACIA RESEARCH CORPS Sale	Director	SSale	−50K sh	$29.61	−$1.48M	45,757
2010-12-07	ACTGACACIA RESEARCH CORPM Exercise/Conversion	Director	MExercise/Conversion	+2,600 sh	$6.94	+$18K	95,757
2010-12-07	ACTGACACIA RESEARCH CORPM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$5.27	+$79.1K	93,157
2010-12-07	ACTGACACIA RESEARCH CORPM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$5.49	+$82.4K	78,157
2010-12-07	ACTGACACIA RESEARCH CORPM Exercise/Conversion	Director	MExercise/Conversion	+13.2K sh	$7.64	+$101K	58,957
2010-06-16	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock OptionA Award	Director	AAward	−40K sh	—	—	265,000
2010-05-18	ACTGACACIA RESEARCH CORPA Award	Director	AAward	+2,642 sh	—	—	45,757
2010-03-04	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock OptionA Award	Director	AAward	+55K sh	—	—	225,000
2010-01-04	ACTGACACIA RESEARCH CORPA Award	Director	AAward	+3,692 sh	—	—	43,115
2009-10-08	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock OptionA Award	Director	AAward	+70K sh	—	—	170,000
2009-07-17	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock OptionJ Other	Director	JOther	−20K sh	—	—	100,000
2009-07-17	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock OptionJ Other	Director	JOther	−50K sh	$175000.00	−$8.75B	175,000
2009-07-17	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock OptionJ Other	Director	JOther	−10K sh	—	—	165,000
2009-07-17	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock OptionJ Other	Director	JOther	−25K sh	—	—	140,000

Recent filings

Accepted (ET)
Jan 34
FRYKMAN EDWARD W0001209191-18-001573
SEC(opens sec.gov)
Mar 174
ACACIA RESEARCH CORP0001078202-17-000003
SEC(opens sec.gov)
Jan 44
ARROWHEAD PHARMACEUTICALS, INC.0001209191-17-001625
SEC(opens sec.gov)
Aug 54
ACACIA RESEARCH CORP0001078202-16-000008
SEC(opens sec.gov)
Mar 34
ACACIA RESEARCH CORP0001078202-16-000003
SEC(opens sec.gov)
Jan 44
ARROWHEAD RESEARCH CORP0001209191-16-088061
SEC(opens sec.gov)
Mar 64
ARROWHEAD RESEARCH CORP0001181431-15-004303
SEC(opens sec.gov)
Jan 64
ACACIA RESEARCH CORP0001078202-15-000001
SEC(opens sec.gov)
Feb 104
ARROWHEAD RESEARCH CORP0001181431-14-006089
SEC(opens sec.gov)
Jan 64
ACACIA RESEARCH CORP0001078202-14-000001
SEC(opens sec.gov)
Sep 244
ARROWHEAD RESEARCH CORP0001181431-13-050389
SEC(opens sec.gov)
May 84
ARROWHEAD RESEARCH CORP0001181431-13-026206
SEC(opens sec.gov)
Apr 14/A
ARROWHEAD RESEARCH CORP0001181431-13-019553
SEC(opens sec.gov)
Mar 254
ARROWHEAD RESEARCH CORP0001181431-13-018616
SEC(opens sec.gov)
Dec 134
ACACIA RESEARCH CORP0001078202-12-000003
SEC(opens sec.gov)
Oct 24
ARROWHEAD RESEARCH CORP0001181431-12-053084
SEC(opens sec.gov)
Mar 54
ACACIA RESEARCH CORP0001078202-12-000002
SEC(opens sec.gov)

Companies

Address

201 SOUTH LAKE AVENUE SUITE 703

PASADENA, CA, 91101